{
  "image_filename": "table_p7_det_6_004.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p7_det_6_004.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_004",
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "supports_claim": false,
  "explanation": "A table summarizing demographic and clinical characteristics (sex, race/ethnicity, coexisting illnesses, prior influenza vaccination) of participants receiving either a recombinant vaccine (N=279,400), a standard-dose egg-based vaccine (N=395,852), or all vaccinees combined (N=675,252). does not support the claim because the table only presents participant demographics and clinical characteristics, without any data on antibody responses or immunogenicity comparisons between vaccine types. Note: Limited to demographic data; no immunogenicity or antibody titer information is provided in the image.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table summarizing demographic and clinical characteristics (sex, race/ethnicity, coexisting illnesses, prior influenza vaccination) of participants receiving either a recombinant vaccine (N=279,400), a standard-dose egg-based vaccine (N=395,852), or all vaccinees combined (N=675,252).",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only presents participant demographics and clinical characteristics, without any data on antibody responses or immunogenicity comparisons between vaccine types.",
    "confidence_notes": "Limited to demographic data; no immunogenicity or antibody titer information is provided in the image."
  }
}